Uni-Bio Science Group Limited (HKG:0690)
Hong Kong · Delayed Price · Currency is HKD 0.0600
-0.0020 (-3.23%)
Aug 27, 2026, 4:08 PM HKT
Uni-Bio Science Group Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 549.77 | 586.21 | 552.98 | 484.72 | 440.32 | 353.41 | |
Revenue Growth | -6.75% | 6.01% | 14.08% | 10.08% | 24.59% | 69.27% |
Cost of Revenue | 93.59 | 98.65 | 91.91 | 91.9 | 105.43 | 76.4 |
Gross Profit | 456.18 | 487.56 | 461.07 | 392.82 | 334.88 | 277.01 |
Selling, General & Admin | 360.03 | 352.46 | 312.24 | 288.65 | 258.31 | 232.85 |
Research & Development | 45.66 | 39.77 | 52.28 | 35.58 | 35.78 | 50.22 |
Other Operating Expenses | -6.93 | -2.91 | -3.28 | -12.29 | -6.99 | -5.16 |
Operating Expenses | 400.16 | 390.33 | 361.42 | 311.93 | 287.64 | 281.84 |
Operating Income | 56.02 | 97.23 | 99.65 | 80.88 | 47.24 | -4.83 |
Interest Expense | -1.62 | -1.51 | -1.19 | -0.78 | -0.38 | -0.48 |
Interest & Investment Income | 3.06 | 3.06 | 3.35 | 1.35 | 1.3 | 0.47 |
Earnings From Equity Investments | 0.27 | 0.27 | -0 | - | - | - |
Other Non Operating Income (Expenses) | -1.83 | -1.83 | -12.32 | -4.94 | -2.17 | 2.72 |
EBT Excluding Unusual Items | 55.9 | 97.23 | 89.48 | 76.51 | 45.99 | -2.12 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.04 |
Gain (Loss) on Sale of Assets | -0.08 | -0.08 | -0.57 | -0.61 | -0.76 | -2.63 |
Asset Writedown | - | - | - | - | - | 0 |
Legal Settlements | - | - | - | - | -2.31 | -15.61 |
Other Unusual Items | 4.37 | 4.37 | 2.25 | - | 0.36 | 0.3 |
Pretax Income | 60.2 | 101.52 | 91.17 | 75.9 | 43.29 | -20.01 |
Income Tax Expense | 11.66 | 8.19 | 8.4 | 5.02 | 4.78 | -0.42 |
Net Income | 48.54 | 93.33 | 82.77 | 70.88 | 38.51 | -19.59 |
Net Income to Common | 48.54 | 93.33 | 82.77 | 70.88 | 38.51 | -19.59 |
Net Income Growth | -46.86% | 12.75% | 16.79% | 84.04% | - | - |
Shares Outstanding (Basic) | 5,978 | 5,971 | 6,140 | 6,365 | 6,361 | 6,372 |
Shares Outstanding (Diluted) | 5,978 | 5,971 | 6,140 | 6,365 | 6,361 | 6,372 |
Shares Change | -1.09% | -2.75% | -3.53% | 0.07% | -0.17% | -0.57% |
EPS (Basic) | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | -0.00 |
EPS (Diluted) | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | -0.00 |
EPS Growth | -46.47% | 15.73% | 21.44% | 83.35% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -10.31 | 36.56 | 28.71 | 39.11 | 20.23 | 3.61 |
Free Cash Flow Per Share | -0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
Dividend Per Share | 0.003 | 0.003 | 0.003 | - | - | - |
Dividend Growth | 13.00% | 13.00% | - | - | - | - |
Gross Margin | 82.98% | 83.17% | 83.38% | 81.04% | 76.05% | 78.38% |
Operating Margin | 10.19% | 16.59% | 18.02% | 16.69% | 10.73% | -1.37% |
Profit Margin | 8.83% | 15.92% | 14.97% | 14.62% | 8.75% | -5.54% |
Free Cash Flow Margin | -1.88% | 6.24% | 5.19% | 8.07% | 4.59% | 1.02% |
EBITDA | 63.15 | 108.32 | 112.08 | 92.55 | 59.53 | 10.88 |
EBITDA Margin | 11.49% | 18.48% | 20.27% | 19.09% | 13.52% | 3.08% |
D&A For EBITDA | 7.12 | 11.09 | 12.44 | 11.66 | 12.29 | 15.71 |
EBIT | 56.02 | 97.23 | 99.65 | 80.88 | 47.24 | -4.83 |
EBIT Margin | 10.19% | 16.59% | 18.02% | 16.69% | 10.73% | -1.37% |
Effective Tax Rate | 19.37% | 8.07% | 9.21% | 6.62% | 11.03% | - |